Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in GALT — Galectin Therapeutics Inc

CIK 1446194 BALA CYNWYD, PA
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$822,194
-$728,214 QoQ
Shares Held
177,197
-68.1% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Derivatives in GALT

reported options exposure · as of Jun 30, 2026
CallValue
$700,640
CallShares
151,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. GALT ranks #136 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in GALT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $822,194 177,197
2026-06-30 $700,640 151,000
2026-03-31 $1,320,507 473,300
2026-03-31 $123,318 44,200
2026-03-31 $1,550,408 555,702
2025-12-31 $1,193,583 286,919
2025-12-31 $329,056 79,100
2025-12-31 $2,144,896 515,600
2025-09-30 $220,904 52,100
2025-09-30 $1,893,490 446,578
2025-09-30 $292,560 69,000
2025-06-30 $112,463 53,300
2025-06-30 $407,652 193,200
2025-06-30 $102,335 48,500
2025-03-31 $13,840 11,345
2025-03-31 $75,640 62,000
2025-03-31 $555,100 455,000
2024-12-31 $1,732,212 1,342,800
2024-12-31 $13,226 10,253
2024-12-31 $580,758 450,200
2024-09-30 $802,175 291,700
2024-09-30 $224,034 81,467
2024-09-30 $43,175 15,700
2024-06-30 $457,277 202,335
2024-06-30 $2,187,906 968,100
2024-03-31 $860,055 359,856
2024-03-31 $101,814 42,600
2023-12-31 $131,339 79,120
2023-12-31 $23,904 14,400
2023-09-30 $28,992 15,100
2023-09-30 $59,458 30,968
2023-06-30 $36,410 25,285
2023-06-30 $54,864 38,100
2023-03-31 $63,690 30,329
2023-03-31 $110,880 52,800
2022-12-31 $26,894 23,800
2022-12-31 $53,344 47,208
2022-12-31 $76,501 67,700
2022-09-30 $120,131 73,700
2022-09-30 $28,663 17,585
2022-09-30 $258,844 158,800
2022-06-30 $56,723 43,300
2022-06-30 $143,576 109,600
2022-06-30 $42,348 32,327
2022-03-31 $169,211 105,100
2022-03-31 $301,231 187,100
2022-03-31 $129,540 80,460
2021-12-31 $350,978 169,555
2021-12-31 $272,826 131,800
2021-12-31 $299,736 144,800